Evidence map›Paper›PMID 27743930›Full record

ArticleNeuropharmacology2017

Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism.

Amit Modgil, Manasa L Parakala, Michael A Ackley, James J Doherty, Stephen J Moss, Paul A Davies

Open access · bronzeAbstract read
In one paragraph

Article in Neuropharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Cys-loop receptors on cannabinoids: All high?Frontiers in physiology · 2022
    Pooled it
  2. SAGE-217, A Novel GABAClinical pharmacokinetics · 2020
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  8. Article
  9. Neurosteroids: a lifelong impact on brain health.Frontiers in behavioral neuroscience · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Neurosteroids: mechanistic considerations and clinical prospects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  17. Article
  18. GABATrends in pharmacological sciences · 2023
    Review
  19. Neurosteroid influence on affective tone.Neuroscience and biobehavioral reviews · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Amit ModgilTufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, USA.
Manasa L ParakalaTufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, USA.
Michael A AckleySage Therapeutics, Inc., 215 First St, Cambridge, MA, USA.
James J DohertySage Therapeutics, Inc., 215 First St, Cambridge, MA, USA.
Stephen J MossTufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, USA; Department of Neuroscience, Physiology and Pharmacology, University College, London WC1E6BT, United Kingdom.
Paul A DaviesTufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, USA. Electronic address: paul.davies@tufts.edu.
Tufts University · USSage Therapeutics (United States) · US

Funding

Mechanisms that determine Glutamine synthetase activity in the brainR01NS081986 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2012 to 2022
$3.7M
Constructing inhibitory synapsesR01NS051195 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2006 to 2014
$3.2M
Studies on the structure of gamma-aminobutyric acid type A receptor subtypesR01MH118263 · NIMH · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2019 to 2023
$2.4M
Modulation of KCC2 activity and the postnatal development of synaptic inhibitionR01NS101888 · NINDS · TUFTS UNIVERSITY BOSTON · PI DEEB, TAREK ZIAD, MOSS, STEPHEN J · 2017 to 2021
$2.3M
Novel actions of neurosteroids on GABA (A) receptor traffickingR01MH097446 · NIMH · TUFTS UNIVERSITY BOSTON · PI DAVIES, PAUL ANDREW, MOSS, STEPHEN J · 2013 to 2017
$2.1M
Deficits in KCC2 activity and the pathophysiology of Status EpilepticusR01NS087662 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2014 to 2018
$2.0M
The role of ubiquitination in regulating GABA(A) receptor functional expressionR01NS056359 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2007 to 2010
$1.4M
Mechanisms that determine the activity of glutamine synthetase in the brainR21NS103865 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2018 to 2019
$454k
Ethanol Modulation of Zinc-Activated ChannelsR21AA017938 · NIAAA · TUFTS UNIVERSITY BOSTON · PI DAVIES, PAUL ANDREW · 2009 to 2010
$452k
Impaired KCC2 function underlies pharmacoresistant seizuresR21NS080064 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2013 to 2014
$452k
NIAAA NIH HHS R21 AA017938NIMH NIH HHS R01 MH097446NIMH NIH HHS R01 MH118263NINDS NIH HHS R01 NS051195NINDS NIH HHS R01 NS056359NINDS NIH HHS R01 NS081986NINDS NIH HHS R01 NS087662NINDS NIH HHS R01 NS101888NINDS NIH HHS R21 NS080064NINDS NIH HHS R21 NS103865
6 · The paper itself

Abstract

The neuroactive steroid (NAS) tetrahydrodeoxycorticosterone (THDOC) increases protein kinase C (PKC) mediated phosphorylation of extrasynaptic GABA

Indexed as

AnimalsCHO CellsCricetinaeCricetulusDesoxycorticosteroneEnzyme InhibitorsHEK293 CellsHippocampusHumansIndolesMaleMaleimidesMiceMice, Inbred C57BLNeural InhibitionOrgan Culture Techniquesbisindolylmaleimide IDesoxycorticosteroneEnzyme InhibitorsIndolesMaleimidesPregnanoloneProtein Kinase CReceptors, GABA-AtetrahydrodeoxycorticosteroneDentate gyrusGABA receptorNeuroactive steroidProtein kinase C (PKC)Tonic inhibition

Identifiers

PMID27743930
PMCPMC5148695
OpenAlexW2531903693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.